Biggest News Aggregation in the World
📰 Associate Professor Head News

Associate Professor Head News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Associate Professor Head. Real-time updates on events, politics, business and more.

Taysha Gene Therapies Announces Queen's University's Receipt of Clinical Trial Application Approval from Health Canada for Phase 1/2 Clinical Trial of TSHA-101 for the Treatment of Infantile GM2 Gangliosidosis | DNA RNA and Cells

Hits: 889 TSHA-101 to be first bicistronic vector evaluated in human clinical trials; TSHA-101 designed to deliver both HEXA and HEXB transgenes within a single AAV9 vector construct TSHA-101 CTA is the second clinical trial clearance received, in addition to TSHA-118’s open investigational new drug application for CLN1 Interim data from Phase 1/2 trial anticipated in 2021 DALLAS, TX, USA I December 21, 2020 I Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy comp...
United States Suyash Prasad Jagdeeps Walia Head Of Research I Taysha Gene Therapies Inc Queen University

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science